logo

Sonoma Pharmaceuticals, Inc. (SNOA)



Trade SNOA now with
  Date
  Headline
7/8/2019 4:11:03 PM Sonoma Pharma Q4 Loss/share $2.45 Vs. Loss $8.45 Year Ago
11/17/2018 11:50:53 AM Sonoma Pharma Announces Pricing Of Public Offering Of Units
10/17/2018 7:08:07 AM Sonoma Pharma Launches New Ceramax Skin Barrier Lotion
9/26/2018 7:08:36 AM Sonoma Pharma Licenses Antimicrobial Hypochlorous Acid Eye Solution For Management Of Blepharitis To Brill Pharma
9/19/2018 7:06:05 AM Sonoma Pharma Appoints Phillipe Weigerstorfer To Board Of Directors
8/28/2018 7:07:14 AM Sonoma Pharma Says Results From Study Of Sonoma’s Performance-Stabilized HOCl In Management Of Acne Vulgaris
6/13/2018 4:07:49 PM Sonoma Pharmaceuticals Q4 Loss/share $0.93 Vs. Loss $0.57 Year Ago
5/8/2018 7:06:48 AM Sonoma Pharma Names Marc Umscheid COO
4/17/2018 7:05:02 AM Sonoma Pharma Gets Four New UAE Regulatory Approvals That Include Acne And Anti-Fungal Products
4/5/2018 7:06:24 AM Sonoma Pharma Gets New 510(k) Clearance From FDA For Antimicrobial Post-therapy Gel
3/2/2018 8:05:30 AM Sonoma Pharmaceuticals Prices Public Offering Of Up To 1.43 Mln Shares At $3.50 Per Share
1/9/2018 7:13:02 AM Sonoma Receives Three New Regulatory Approvals From UAE Ministry Of Health & Prevention
12/5/2017 7:07:19 AM Sonoma Pharma Announces Second FDA Approval For Alevicyn SG Antipruritic Spray Gel For Management Of Atopic Dermatitis
11/16/2017 7:49:43 AM Sonoma Reports FDA Approval Of Expanded Indication For Alevicyn To Add Antimicrobial Language